Healthcare Realty Trust Inc
For the period ended Oct 29, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 29, 2026 · Filed Oct 29, 2026
Use the contents to explore the available documents and sections.
HR$19.20+0.7%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · FFO, Normalized FFO, & FAD
FFO, Normalized FFO, & FAD
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
| THIRD QUARTER ENDED · YEAR TO DATE · FULL YEAR | |||||
|---|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | 2025 | |
| Net loss attributable to common stockholders | $(15,755) | $(57,738) | $(59,325) | $(260,462) | $(246,071) |
| Net loss attributable to common stockholders per diluted share | $(0.05) | $(0.17) | $(0.18) | $(0.75) | $(0.71) |
| Gain on sales of real estate assets | (2,476) | (76,771) | (16,966) | (99,678) | (235,389) |
| Impairments of real estate assets | 16,152 | 104,362 | 58,909 | 255,384 | 361,090 |
| Real estate depreciation and amortization | 127,020 | 143,187 | 381,896 | 451,411 | 586,146 |
| Non-controlling loss from operating partnership units | (194) | (806) | (741) | (3,698) | (3,497) |
| Unconsolidated JV depreciation, amortization, gain and impairment | 6,919 | 6,688 | 17,733 | 20,111 | 27,769 |
| NAREIT FFO | $131,666 | $118,922 | $381,506 | $363,068 | $490,048 |
| NAREIT FFO per common share - diluted | $0.38 | $0.34 | $1.10 | $1.02 | $1.38 |
| Transaction costs | 1,693 | 125 | 4,102 | 1,729 | 2,029 |
| Debt financing costs | 25 | 3,493 | 1,917 | 3,493 | 5,107 |
| Restructuring and severance-related charges | 2,031 | 12,046 | 12,615 | 22,849 | 26,318 |
| Merger-related fair value adjustment | 9,107 | 10,715 | 30,251 | 31,741 | 42,593 |
| Other | 1,406 | 39 | 3,622 | 3,918 | 2,851 |
| Normalized FFO | $145,928 | $145,340 | $434,013 | $426,798 | $568,946 |
| Normalized FFO per common share - diluted | $0.42 | $0.41 | $1.25 | $1.20 | $1.61 |
| Non-real estate depreciation and amortization | 749 | 1,139 | 2,200 | 3,592 | 6,114 |
| Non-cash interest amortization, net | 1,495 | 1,384 | 4,242 | 3,731 | 5,126 |
| Straight-line amortization, net | (12,332) | (6,924) | (36,338) | (22,837) | (29,392) |
| Stock-based compensation | 4,561 | 3,386 | 12,909 | 10,301 | 13,609 |
| Unconsolidated JV non-cash items | (169) | (463) | (423) | (1,073) | (1,420) |
| Other | — | 146 | — | 370 | 952 |
| Maintenance capital and LCs | (30,058) | (27,155) | (84,211) | (86,455) | (115,633) |
| FAD | $110,174 | $116,853 | $332,392 | $334,427 | $448,302 |
| Quarterly dividends and OP distributions | $83,347 | $85,536 | $251,515 | $305,862 | $391,368 |
| FFO wtd avg common shares outstanding - diluted 1 | 345,568 | 354,690 | 348,292 | 354,294 | 354,454 |
1 The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstandingof 722,102 for the three months ended September 30, 2026. Also includes the diluted impact of 4,229,701 OP units outstanding.
| HEALTHCARE REALTY | Return to Table of Contents | Q3 2026 SUPPLEMENTAL INFORMATION 8 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.